News
STEM Healthcare appoints Tim Missey as US President
Global benchmarking company STEM Healthcare (STEM) is pleased to announce the appointment of Tim Missey as US President effective June 4th 2018. Tim joins STEM from Mallinckrodt Pharmaceuticals where he was the General Manager for Neurology...
News
LANXESS: Matthias L. Wolfgruber voted in as new Chairman of the Supervisory Board
Dr. Matthias L. Wolfgruber (64) is the new Chairman of the Supervisory Board of LANXESS AG. At its constituent meeting, the Supervisory Board of the specialty chemicals company elected the doctor of chemistry and former CEO...
News
6 months until DSCSA…industry comments
DSCSA( Drug Supply chain Security Act):The bill was signed by President Obama on 27th November, 2013 to amend the federal Food, Drug and Cosmetic Act to grant the FDA with more authority to regulate and monitor the manufacturing of...
News
Amgen Enters Groundbreaking Collaboration To Improve Symptom Management During Cancer Treatment
Amgen announced a groundbreaking collaboration with the National Cancer Institute (NCI), the FCC Connect2Health Task Force, the University of Kentucky (UK) Markey Cancer Center and the University of California, San Diego (UCSD) Design Lab to support the improvement of...
News
Bayer Highlights Latest Oncology Research at ASCO 2018
Bayer announced that the latest research across its growing oncology portfolio will be presented at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place June 1-5 in Chicago. Highlights include data...
News
Celgene Corporation to Webcast at Upcoming Investor Conferences and Events
Celgene Corporation plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations...
News
Astellas Announces Abstracts Highlighting Growing Oncology Portfolio to be Presented at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Astellas Pharma Inc announced hat a wide selection of abstracts highlighting the Company's diverse oncology portfolio across a broad range of cancers have been accepted for oral and poster presentation at the 2018 American Society of Clinical Oncology (ASCO)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















